AMN Healthcare Q1 revenue falls 16% to $690 million; posts $1 million net loss
AMN Healthcare reported first-quarter 2025 revenue of $690 million, down 16% from a year earlier, and a net loss of $1 million, or $0.03 per diluted share, compared with net income of $17 million, or $0.45 per share, in the first quarter of 2024. Adjusted diluted EPS fell to $0.45 from $0.97, and second-quarter revenue guidance of $645 million to $660 million points to a further decline of 11% to 13% from the prior year, which weighs on the outlook for shareholders.
Key points
- Q1 2025 revenue was $690 million, down 16% year over year and 6% sequentially; gross margin was 28.7%, down 270 basis points year over year.
- Net loss was $1 million, or ($0.03) per diluted share, versus net income of $17 million, or $0.45 per share, in Q1 2024.
- Second-quarter 2025 revenue guidance is $645 million to $660 million, 11% to 13% lower than the prior year.
- Cash flow from operations was $93 million in the first quarter, and the company reduced debt by $60 million.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.